- Home
- Prostate Cancer Therapeutics A Global Market Perspective
Prostate Cancer Therapeutics A Global Market Perspective
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution
- $ 3 500
- Industry report
- by GBI Research
- May 2012
- 129 pages
Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution Summary GBI Research, the leading business intelligence provider, has released its latest research ?Generics in Cardiovascular Diseases ...
Industries: Pathology | Countries: World
Biogen Idec Inc. (Symbol:BIIB) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2012
- 54 pages
Biogen Idec Inc. (Biogen Idec) is a biotechnology company, which is involved in the development, manufacturing and commercialization of novel therapies used in the areas of oncology, neurology and immunology. Its four therapeutic products available in the market include AVONEX, RITUXAN, TYSABRI and ...
Industries: Pathology | Countries: United States, World
Ego Pharmaceuticals Pty Ltd SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- by Global Data
- May 2012
- 16 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...
Industries: Pathology | Countries: Australia, Singapore, World
Chiesi Farmaceutici SpA SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- by Global Data
- May 2012
- 28 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...
Industries: Pathology | Countries: Italy, France, World, Brazil, United States
GlaxoSmithKline plc (Symbol:GSK) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2012
- 80 pages
GlaxoSmithKline plc (GSK) is a UK-based pharmaceutical, biological, and healthcare company engaged in the development, manufacture and marketing of pharmaceutical and consumer health related products. GSK operates in two industry segments: Pharmaceuticals and Consumer Healthcare. The company, through ...
Industries: Pathology | Countries: United Kingdom, World
Narhex Life Sciences Limited (Symbol:NLS) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- by Global Data
- May 2012
- 27 pages
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Narhex Life Sciences Limited SWOT Analysis report provides you a strategic ...
Industries: Pathology | Countries: China, World, Australia
Sevelamer - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Pathology | Countries: Europe, World
Sitagliptin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Pathology | Countries: Europe, World
Paricalcitol - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Pathology | Countries: Europe, World
Sorafenib - Key patent, SPC, and data exclusivity expiry (44 country coverage)
- $ 1 363
- Industry report
- by GenericsWeb
- May 2012
Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players. This Pipeline Selecto ...
Industries: Pathology | Countries: Europe, World
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- 00 1 718 618 48 97
Reportlinker.com © Copyright 2012. All rights reserved
